Skip to content

Clinical trials

Completed Observational Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Phase: Observational Status: Completed Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20071
20083
20091
20101
20114
20121
20142
20161
20172
20181
20191
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie (prior sponsor, Abbott)8
Abbott2
Amgen2
Benha University1
Centre Hospitalier Universitaire de Saint Etienne1
Columbia University1
Fifth Affiliated Hospital, Sun Yat-Sen University1
Hospital General Ajusco Medio1
Huashan Hospital1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary26
Renal Insufficiency, Chronic11
Kidney Failure, Chronic6
Chronic Kidney Disease-Mineral and Bone Disorder5
Fractures, Bone2
Bone Diseases1
Bone Diseases, Metabolic1
Calcinosis1
Cardiovascular Diseases1
Diabetic Nephropathies1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.